Brimonidine Tartrate/timolol Maleate Solution/ Drops
Product Images NDC 72485-634

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate/timolol Maleate (NDC 72485-634). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 mL Carton (Brimonidine Timolol 10 mL Carton)

10 mL Carton (Brimonidine Timolol 10 mL Carton)
This text appears to be the description of a medication called Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution. It is used for the treatment of eye conditions and comes in a 10 mL sterile container. The solution contains 0.2% Brimonidine Tartrate and 0.5% Timolol. It should be stored at a temperature between 20°C and 25°C and protected from light. The recommended dosage is one drop, twice daily in the affected eye(s). The package is not child-resistant. The medication is distributed by Armas Pharmaceuticels, Inc. in Freshold, NJ, USA, and manufactured by Opiapharm AG in Switzerland.*
FDA Label Image

10 mL Container (Brimonidine Timolol 10 mL Container)

FDA Label Image

5 mL Carton (Brimonidine Timolol 5 mL Carton)

5 mL Carton (Brimonidine Timolol 5 mL Carton)
This is a description of an ophthalmic solution called Brimonidine Tartrate/Timolol Maleate. It is used to treat certain eye conditions. Each solution contains 0.2% Brimonidine Tartrate and 0.5% Timolol. It is prescribed for use in the affected eye(s) twice daily, with one drop each time. The solution comes in a 5mL sterile bottle and should be stored between 20°C and 95°C. It is important to protect it from light. The package is not child resistant. The product is distributed by Ammas Pharmaceuticals, Inc. in New Jersey, USA, and manufactured by CompnarmAS ietiftosse in Hetiingen, Switzerland for Sentiss.*
FDA Label Image

5 mL Container (Brimonidine Timolol 5 mL Container)

FDA Label Image

Brimonidine Tartrate Chemical Structure (Image 1)

FDA Label Image

Timolol Maleate Chemical Structure (Image 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.